Why is precision urgently needed for GLP-1 coverage? Demand is surging, costs remain high, and patient responses vary. Predictive biomarkers can help payors prioritize coverage where GLP-1s deliver the most value, while protecting affordability and access. #GLP1 #PrecisionMedicine #ValueBasedCare

Those lovely people @actionforme.bsky.social have shared the recording of the webinar covering presentation of @precisionlife.bsky.social LOCOME results. #MECFS #longcovid www.youtube.com/watch?v=ITZ3...

WEBINAR TODAY: Our researchers are unpacking the new ME genetics study today - join the live webinar to hear the findings first-hand and get your questions answered. 📅 Today 🕑 2PM GMT 🔗 Register: us02web.zoom.us/webinar/regi... #pwME #MECFS #longCOVID #MissingMillions

Helen Baxter, Patient Advocate and PPI Representative: "These results greatly enhance our understanding of the biology of ME and present opportunities for drug repurposing which affords hope to the millions of people living with #ME and #longCOVID around the world." @precisionlife.bsky.social

LOCOME Project: Major #ME and #LongCOVID Genetics Findings Announced. Today we are excited to share landmark new findings from the LOCOME project. www.medrxiv.org/content/10.6... @precisionlife.bsky.social

Delighted how @precisionlife.bsky.social and @actionforme.bsky.social et al used consented @decodemestudy.bsky.social data to -replicate #MEcfs genetic signal & -show its shared/distinct genetics with Long Covid. Next: replicate ME/CFS subtypes w/ targeted therapies www.medrxiv.org/content/10.6...

(1/4) 🧬 @precisionlife.bsky.social has released exciting results from the LOCOME project Using DecodeME and other datasets, LOCOME has identified a number of genetic signals and biological pathways that may be involved in ME.

New myalgic encephalomyelitis (ME, also known as ME/CFS) genetics study reveals 250+ core genes, shared mechanisms with long COVID, and dozens of drug repurposing opportunities. This would not have been possible without the thousands of people with ME who contributed their data. Thank you.

We’ve partnered with Ovation.io to identify biomarkers that predict which patients will respond safely and effectively to GLP-1 therapies. The goal: help payors and providers achieve the best, most cost-effective outcomes for patients using GLP-1. ➡️ www.precisionlife.com/glp1 for more.

In a new article in Healthcare Leader, our CEO Steve Gardner explains how by understanding the biological mechanisms behind chronic conditions we can now predict and prevent complex diseases, improve diagnosis, treatment and patient outcomes. Read it here: precisionlife.com/healthcarele...

Why would anyone take on what is arguably the most complex of the complex, chronic diseases? That’s the question Cort Johnson, founder of leading patient advocacy site Health Rising, asks in his latest feature about our work in ME/CFS and Long COVID. ➡️ www.healthrising.org/blog/2025/10...

Yesterday at #TechBioUK - hosted by @bia-uk.bsky.social - our CEO Steve Gardner joined leaders from AstraZeneca, Healx and Recursion to explore the real-world impact of AI in drug development and healthcare – and what’s needed for it to reach its full potential. What do you think?

Our 2025 Big Survey is now open! 🎉 For more information, our FAQs, and to take part, head to our web page: www.actionforme.org.uk/research-campaigns/our-research-work/big-survey/ Thank you for supporting our research💙 🤝in collaboration with @durhamimh.bsky.social @kacheston.bsky.social

Thank you to Golda Arthur for inviting me to be on the Overlooked Pod. A curation of conversations about women's health from patients, clinicians and scientists. Highlighting @precisionlife.bsky.social's work in #endometriosis and #womenshealth check out the series overlookedpod.com/episode/a-ne...

Our SVP of Bioinformatics, Sayoni Das, shared new insights at #WomenInBiotech: 75 novel genes linked to #endometriosis, confirmed across diverse populations. A step toward faster diagnosis, better treatments, and real progress in #WomensHealth. 🔗 Study pre-print: www.medrxiv.org/content/10.1...

Our latest study, now in pre-print, has identified & validated 75 new genes linked to #endometriosis. Actionable insights that will help shorten the 7–10 year diagnostic delay and lead to more effective, personalized treatments. 🔗 www.medrxiv.org/content/10.1... #WomensHealth #PrecisionMedicine

This week we took part in the launch of Victoria House - London's new home for science and innovation. Our team showcased Mechanostics® - accelerating diagnosis, improving outcomes, reducing costs, and moving chronic disease care from treatment to prevention. #PrecisionMedicine #PrecisionLife

🎥 As part of today’s recognition of #SevereME, we’re sharing this recent presentation by our Co-founder, Rowan Gardner (@rowanbio.bsky.social‬), given at International ME Conference: 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗧𝗲𝘀𝘁𝘀 𝗮𝗻𝗱 𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗠𝗘.

𝗧𝗼𝗱𝗮𝘆 𝗶𝘀 𝗦𝗲𝘃𝗲𝗿𝗲 𝗠𝗘 𝗗𝗮𝘆 – a moment to acknowledge the strength, resilience, and determination of those living with the most debilitating forms of Myalgic Encephalomyelitis.

Millions are still waiting for answers. Ahead of #SevereMEAwarenessDay, we’re reaffirming our support and using genetic insights to develop the first non-invasive mechanostic tests to accelerate diagnosis and improve care. 🔗 precisionlife.com/blog-support... #MECFS #LongCOVID

We fully support our partners at @actionforme.bsky.social in their response to the UK government's ME/CFS Delivery Plan as a positive and necessary step forward – but that much more is needed to deliver real change, faster, for people with ME. #pwME #MECFS #MyalgicE #MyalgicEncephalomyelitis

1-hour recording from AfME’s Genetics Centre of Excellence webinar: "Presentations from Audrey Ryback, Research Fellow at the University of Edinburgh (funded by Action for ME), and PrecisionLife, our Partners in the LOCOME research project." www.youtube.com/watch?v=zhNt... #MEcfs #CFS #PwME

Chronic diseases overwhelm health systems, yet most lack accurate risk prediction or effective treatment. In a new insight article, our CEO explores how mechanism-based precision medicine can change that. 🔗 precisionlife.com/future-now #PrecisionMedicine #PrecisionLife

Delighted to feature in the @bia-uk.bsky.social report on functional genomics as an example of its transformative power in UK healthcare. Proud to work at the intersection of AI and genomics - understanding complex biology to predict & prevent chronic diseases. 🔗 bioindustry.org/resource-rep...

Watch our full presentation (clip below) in the recent @actionforme.bsky.social webinar on ME/CFS & long COVID. We explore genetic risk factors, protective biology, and precision biomarkers that could transform diagnosis and treatment. 🎥 precisionlife.com/webinar-upda... #MECFS #LongCOVID

PrecisionLife CEO, Steve Gardner, spoke yesterday on BBC Radio 4’s Today Show about the UK industrial strategy & why prioritizing life sciences is vital for economic growth. #LifeSciences #PrecisionMedicine

Ahead of Global MND Awareness Day, we're sharing our recent work uncovering the mechanisms behind ALS, new protective biology, and a path to non-invasive, personalized diagnosis and treatment. Read more: precisionlife.com/publication-... #ALS #MND

New in Bio-IT World: how PrecisionLife is enabling mechanism-based precision medicine for complex diseases like ME/CFS, long COVID, ALS & endometriosis. Read the article: www.bio-itworld.com/news/2025/06... #precisionmedicine #biomarkers #PrecisionLife

⏰ Last chance to register! Our webinar with @actionforme.bsky.social on #MECFS & #LongCOVID is tomorrow. Join for the latest research insights and their implications for the prediction, treatment and prevention of the conditions. 🔗 Register: precisionlife.com/webinar-upda... #pwME #MyalgicE

Rowan Gardner (@rowanbio.bsky.social) joins global leaders at Oxford Nanopore’s (@nanoporetech.com) Informatics Day tomorrow to discuss how AI and genomics can unlock new insights in complex disease biology. 🔗 nanoporetech.com/about/events... #LondonCalling25 #Genomics #AI #PrecisionMedicine

We will share and discuss the latest ME/CFS & Long COVID genetic findings in a free webinar on 6 June, hosted by @actionforme.bsky.social. Speakers include Steve Gardner, Audrey Ryback, and Sonya Chowdhury. 🎟️ Register: precisionlife.com/webinar-upda... #MECFS #LongCOVID #precisionmedicine

Heading to #WCE2025? We'll be there sharing new insights into genetic risk, patient stratification & diagnostic tools for #endometriosis and #womenshealth. Come meet us in Sydney & explore the future of #precisionmedicine. 🔗 precisionlife.com/news-and-eve...

🧬 𝙄𝙣𝙨𝙞𝙜𝙝𝙩𝙨: 𝗨𝗻𝗰𝗼𝘃𝗲𝗿𝗶𝗻𝗴 𝗡𝗲𝘄 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗶𝗻 𝗠𝗘/𝗖𝗙𝗦 𝗮𝗻𝗱 𝗟𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 This month’s 𝘐𝘯𝘴𝘪𝘨𝘩𝘵𝘴 newsletter explores groundbreaking progress in our understanding of complex disease biology. Read more here: em.precisionlife.com/insights-may... #PrecisionMedicine #PrecisionLife

🔬 𝗠𝗘 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗪𝗲𝗲𝗸 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗣𝗶𝗼𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻 𝗠𝗘/𝗖𝗙𝗦 𝗮𝗻𝗱 𝗟𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 This #MEAwarenessWeek, we're proud to share our progress in understanding and treating #MECFS and #LongCOVID. 🔗 precisionlife.com/longcovid-me...

1/4 Today is #WorldMEDay 🧡 We are supporting the World ME Alliance to help debunk 6 of the most common myths about ME & share the medical facts about ME that everyone should know

📢 This #WorldMEDay, we’re proud to share real progress towards better outcomes for people living with ME/CFS and Long COVID.

Reproducibility of Genetic Risk Factors for Long COVID Across Diverse Populations translational-medicine.biomedcentral.com/articles/10.... #LongCOVID #MECFS #POTS #Genetics #DataScience #PrecisionMedicine

PrecisionLife & Metrodora confirm the first reproducible genetic signatures for #LongCOVID across ancestries. Just in time for #WorldMEDay, this marks major progress for patients with complex chronic conditions. 🔗 Read: precisionlife.com/publication-... #PrecisionMedicine #MECFS #Genomics

Very proud of our team @precisionlife.bsky.social and our partners today translational-medicine.biomedcentral.com/articles/10.... Reproducing insights across populations 🧬🖥️

How can biotech and pharma partner more effectively in CNS & neurology? 🧠 Catch @rowanbio.bsky.social and leaders from Otsuka, Eli Lilly, Avata Biosciences & Lumina Life Sciences at LSX World Congress to share strategies for success. #LSXWorld #CNS #Partnerships precisionlife.com/news-and-eve...

We’re heading to Abu Dhabi Global Health Week to share how PrecisionLife is enabling th eprediction and prevention of major chronic diseases with groundbreaking insights into the mechanisms driving complex conditions. Let’s connect. 🌍 🔗 precisionlife.com/news-and-eve... #ADGHW2025 #PrecisionMedicine

🧬 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗯𝗲𝘁𝘁𝗲𝗿 𝘄𝗮𝘆𝘀 𝘁𝗼 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗲 𝗮𝗻𝗱 𝘁𝗿𝗲𝗮𝘁 𝘄𝗼𝗺𝗲𝗻 𝘄𝗶𝘁𝗵 𝗲𝗻𝗱𝗼𝗺𝗲𝘁𝗿𝗶𝗼𝘀𝗶𝘀 🧬 Our Product Strategy Lead Hannah Bibby spoke to The Pathologist about TRANSCEND – using multi-omics + AI to uncover the biology and enable better diagnosis + treatment. Read the Q&A: thepathologist.com/issues/2025/...

It’s #WorldHealthDay 🌍 Chronic diseases cause 80% of healthcare costs & affect billions. At PrecisionLife we’re working to predict, treat & prevent them—improving health outcomes & reducing cost of care so people can live longer, healthier lives. 🔗 precisionlife.com/healthspan #PrecisionMedicine

PrecisionLife Co-founder and Chief Business & Investment Officer, Rowan Gardner @rowanbio.bsky.social, will be chairing the sold out 𝗙𝗶𝗻|𝗧𝗲𝗰𝗵|𝗕𝗶𝗼 𝗮𝘁 𝗖𝗮𝗻𝗮𝗿𝘆 𝗪𝗵𝗮𝗿𝗳 event this evening. For more details about this and future events, visit: level39.co/event/fintec...

Thank you to @catelawrence.bsky.social for covering @precisionlife.bsky.social work in #LongCOVID. Great to be included in the @tech.eu platform. tech.eu/2025/03/17/i... #ILCAD2025

Last week we shared a significant advancement in our understanding of long COVID and its implications for precision medicine.​ This breakthrough exemplifies our commitment to driving precision medicine in complex chronic diseases, offering hope to billions affected worldwide.​ #PrecisionMedicine

In addition to discovering and reproducing detailed long COVID genetic associations for the first time, PrecisionLife researchers were also the first to identify genetic risk factors for ME/CFS. To learn more about our research into long COVID and ME/CFS, visit precisionlife.com/longcovid-me

In addition to discovering and reproducing detailed long COVID genetic associations for the first time, PrecisionLife researchers were also the first to identify genetic risk factors for ME/CFS. To learn more about our research into long COVID and ME/CFS, visit precisionlife.com/longcovid-me

🔬 𝗟𝗮𝗻𝗱𝗺𝗮𝗿𝗸 𝗟𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 𝗦𝘁𝘂𝗱𝘆 𝗖𝗼𝗻𝗳𝗶𝗿𝗺𝘀 𝗞𝗲𝘆 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻𝘀 𝗔𝗰𝗿𝗼𝘀𝘀 𝗗𝗶𝘃𝗲𝗿𝘀𝗲 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀: 𝗣𝗮𝘃𝗶𝗻𝗴 𝘁𝗵𝗲 𝗪𝗮𝘆 𝗳𝗼𝗿 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 & 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 We’re excited to share a major breakthrough in 𝗹𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵. 🔍 Read the full press release: precisionlife.com/news-and-eve...

Following the exciting announcement of our TRANSCEND project to advance precision medicine solutions for endometriosis (precisionlife.com/transcend-en...), we’re looking forward to attending the EndoFound Annual Medical Conference in NYC (Feb 28 – Mar 1). www.endofound.org/medicalconfe...